Literature DB >> 6289637

Epstein-Barr virus antigens-a challenge to modern biochemistry.

D A Thorley-Lawson, C M Edson, K Geilinger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6289637     DOI: 10.1016/s0065-230x(08)60428-5

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  8 in total

1.  Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB.

Authors:  M Gong; T Ooka; T Matsuo; E Kieff
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

2.  Detection by monoclonal antibodies of an early membrane protein induced by Epstein-Barr virus.

Authors:  N Balachandran; J Pittari; L M Hutt-Fletcher
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

3.  Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame.

Authors:  D E Oba; L M Hutt-Fletcher
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

4.  Synthesis and processing of the three major envelope glycoproteins of Epstein-Barr virus.

Authors:  C M Edson; D A Thorley-Lawson
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

5.  Characterization of an antigen whose cell surface expression is induced by infection with Epstein-Barr virus.

Authors:  B Sugden; S Metzenberg
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

6.  Modification of Epstein-Barr virus replication by tunicamycin.

Authors:  L M Hutt-Fletcher; N Balachandran; P A LeBlanc
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

7.  Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones.

Authors:  L E Wallace; J Wright; D O Ulaeto; A J Morgan; A B Rickinson
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

8.  Screening for Epstein-Barr and human cytomegalovirus in normal and abnormal cervical smears by fluorescent in situ cytohybridization.

Authors:  H J Schön; B Schurz; R Marz; W Knogler; E Kubista
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.